Global Fund, Nigeria sign agreements worth $225M to prevent, treat malaria

NewsGuard 100/100 Score

The Global Fund to Fight AIDS, Tuberculosis and Malaria and Nigeria on Friday "signed two grant agreements ... worth a total of $225 million to support programs that will prevent and treat malaria," a Global Fund press release reports. According to the press release, the agreements "include an additional $50 million for bed nets, approved in an unusual move by the Global Fund Board that was linked to additional commitments by the government of Nigeria" (8/24). Global Fund Deputy Executive Director Debrework Zewdie "told top government functionaries that the [money] is meant to assure the international community that Nigeria is a worthy partner in the fight to eradicate malaria," ThisDay writes, adding, "During a transformation of the fund's grant management structure this year, Nigeria was identified as one of the 20 'high impact' countries that are now receiving special attention" (8/26). Aigboje Aig-Imoukhuede, CEO of Access Bank and chair of the Friends of the Global Fund Africa, "described the grant as [an] opportunity for Nigeria to show leadership and commitment in the fight against malaria by committing more resources to save lives," the Daily Trust notes (Atonko, 8/26).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New drug combination could reduce malaria infection risk in pregnant women living with HIV